🌎 Geron Downgraded, Koninklijke Philips Upgraded, PVH Initiated and more...

Ratings changes for Jaguar Health, Marin Software, Iteris, Zillow Group, Intuit, Adverum Biotechnologies, Geron and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial. Unsubscribe. VIEW MY PORTFOLIO April 30th, 2024     Titanium Shortage Threatens Industry Titan (ad) A titan of the aerospace industry announced it would no longer purchase titanium from Russia, a key supplier. With a global shortage of the lightweight "wonder metal" already in play, aerospace-grade titanium has become particularly scarce. Will investors find new opportunity amid this titanium crisis? Today's Top Stories Microsoft Analysis: Trends, Predictions & Investment Insight Europe's economy shows signs of life with 0.3% growth in 1st quarter as inflation, energy woes ease Elon's New Device is About to Shock the World (InvestorPlace) CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens? Mexico proudly controls its energy but could find it hard to reach its climate goals Did the Rally in Coca-Cola Company Stock Just Fizzle Out? Stock market today: Wall Street points lower as markets digest earnings ahead of Fed meeting Get more from your stocks in this market (Unstoppable Prosperity) Analyst Sentiment, Revenue Growth Will Lead AbbVie Stock Higher Samsung reports a 10-fold increase in profit as AI drives rebound in memory chip markets 3 Trend-Following Entries for Income Investors How major US stock indexes fared Monday, 4/29/2024 Quick Links MarketBeat All Access My MarketBeat Account Settings Mobile App Analyst Ratings MUST SEE Before May 1 (ad) Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)   American International Group, Inc. (AIG) American International Group (NYSE:AIG) will be releasing earnings after the market closes on Wednesday, May 1, Zacks reports. (Register for Conference Call) (4/29) AIG Appoints Kelly Lafnitzegger Executive Vice President and Chief Human Resources & Diversity Officer (businesswire.com) (4/29) Can AIG Navigate Through Lower Premiums in Q1 Earnings? (zacks.com) (4/29) State Policing: FG Also Misusing The Police – Ex-AIG Alleges (naijanews.com) (4/29) American International Group, Inc. (NYSE:AIG) Shares Sold by Russell Investments Group Ltd. (marketbeat.com)   Bank of America Co. (BAC) Bank of America (NYSE:BAC) had its price target raised by analysts at Oppenheimer Holdings Inc. (    ) from $45.00 to $46.00. They now have an "outperform" rating on the stock. This represents a 22.5% upside from the current price of $37.56. (4/30) Guyasuta Investment Advisors Inc. Sells 386,144 Shares of Bank of America Co. (NYSE:BAC) (marketbeat.com) (4/30) Bank of America (NYSE:BAC) Price Target Raised to $46.00 at Oppenheimer (marketbeat.com) (4/30) Maintaining Buy on Bank of America: Growth and Capital Returns Justify Valuation (markets.businessinsider.com) (4/30) Bank of America Q1 Earnings Transcript (marketbeat.com) (4/29) Steele Capital Management Inc. Invests $727,000 in Bank of America Co. (NYSE:BAC) (marketbeat.com) (4/29) Bank of America (NYSE:BAC) Trading 0.3% Higher (marketbeat.com) (4/29) Japan's currency falls to its weakest since 1990 against the dollar as the yen keeps yelping (marketbeat.com) (4/29) Bank of America Co. (NYSE:BAC) Short Interest Down 10.1% in April (marketbeat.com) (4/29) Stagflation Is Real, Mastercard Stock Now a Sudden Must Have (BAC) (marketbeat.com) (4/29) Sell alert: Expert warns S&P 500 could crash 44% (finbold.com)   Delta Air Lines, Inc. (DAL) (4/30) Delta Air Lines Q1 Earnings Transcript (marketbeat.com) (4/30) Delta Air Lines, Inc. (NYSE:DAL) Given Consensus Recommendation of "Buy" by Brokerages (marketbeat.com) (4/29) Delta Air Lines, Inc. (NYSE:DAL) Shares Sold by New York State Common Retirement Fund (marketbeat.com)   JPMorgan Chase & Co. (JPM) JPMorgan Chase & Co. (NYSE:JPM) declared a quarterly dividend on Tuesday, March 19th. Investors of record on Friday, April 5th will be given a dividend of 1.15 per share by the financial services provider on Tuesday, April 30th. This represents a $4.60 annualized dividend and a yield of 2.38%. The ex-dividend date of this dividend is Thursday, April 4th. This is a positive change from JPMorgan Chase & Co.'s previous quarterly dividend of $1.05. (4/30) UPDATE 3-BBVA, Sabadell to explore possible merger (finance.yahoo.com) (4/30) JPMorgan Chase & Co. Q1 Earnings Transcript (marketbeat.com) (4/30) Can Disney Stock Triple Before 2030? (marketbeat.com) (4/30) GAMMA Investing LLC Makes New $9.02 Million Investment in JPMorgan Chase & Co. (NYSE:JPM) (marketbeat.com) (4/29) JPMorgan Chase's woke DEI style guide nixes terms like 'manpower,' 'blacklist' (msn.com) (4/29) JPMorgan Chase CEO Jamie Dimon Says He Is Worried About 'Stagflation' — Here's Why (msn.com) (4/29) CORRECTED-JPMorgan-backed Brazilian digital bank C6 posts first-ever profit in Q1 (finance.yahoo.com) (4/29) Carlyle Picks JPMorgan, Morgan Stanley for IPO or Sale of StandardAero (finance.yahoo.com) (4/29) JPMorgan Chase & Co. (NYSE:JPM) Stock Price Up 0.4% (marketbeat.com) (4/29) 2 Artificial Intelligence (AI) Stocks to Buy Now That Could Make You a Fortune (fool.com)   Morgan Stanley (MS) (4/30) Morgan Stanley Q1 Earnings Transcript (marketbeat.com) (4/29) Raymond James & Associates Increases Holdings in Morgan Stanley (NYSE:MS) (marketbeat.com) (4/29) Scotiabank names former Morgan Stanley exec as head of global banking, markets unit (reuters.com) (4/29) Morgan Stanley shareholders urged to vote against executive pay (proactiveinvestors.com) (4/29) Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Morgan Stanley for potential violations of federal securities laws (prnewswire.com) Analysts' Upgrades Citizens Financial Services (NASDAQ:CZFS) was upgraded by analysts at Janney Montgomery Scott from a "neutral" rating to a "buy" rating. They now have a $53.00 price target on the stock. This represents a 26.7% upside from the current price of $41.83. Deciphera Pharmaceuticals (NASDAQ:DCPH) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. They now have a $26.00 price target on the stock, up previously from $9.00. This represents a 2.8% upside from the current price of $25.29. Hope Bancorp (NASDAQ:HOPE) was upgraded by analysts at DA Davidson from a "neutral" rating to a "buy" rating. They now have a $12.50 price target on the stock. This represents a 25.6% upside from the current price of $9.95. MSCI (NYSE:MSCI) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "neutral" rating. They now have a $525.00 price target on the stock, up previously from $425.00. This represents a 9.9% upside from the current price of $477.86. Koninklijke Philips (NYSE:PHG) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating.The current price is $26.72. Koninklijke Philips (NYSE:PHG) was upgraded by analysts at UBS Group AG from a "sell" rating to a "neutral" rating.The current price is $26.72. UMB Financial (NASDAQ:UMBF) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $95.00 price target on the stock. This represents a 21.9% upside from the current price of $77.91. View today's most recent analysts' upgrades at MarketBeat.com Biden's $374B Giveaway Into This Sector (ad) Biden's Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here Click here for the full story Analysts' Downgrades Boeing (NYSE:BA) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating.The current price is $172.84. Chegg (NYSE:CHGG) was downgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to an "underperform" rating. They now have a $4.00 price target on the stock, down previously from $7.00. This represents a 32.1% downside from the current price of $5.89. Geron (NASDAQ:GERN) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $4.50 price target on the stock. This represents a 11.4% upside from the current price of $4.04. Paramount Global (NASDAQ:PARA) was downgraded by analysts at Needham & Company LLC from a "buy" rating to a "hold" rating.The current price is $11.91. XP (NASDAQ:XP) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $23.00 price target on the stock, down previously from $30.00. This represents a 7.4% upside from the current price of $21.42. View today's most recent analysts' downgrades at MarketBeat.com I turned my laptop into a Wall Street grade trading system (ad) I Built A Stock Prediction System Based on Underlying Reason Stocks Rise And Fall… Here's the story… In 2016 I walked away from my former hedge fund… It was my first crack at being a "stay-at-home trader" I no longer had 8+ monitors… I didn't have millions of dollars to trade with… And I no longer had access to their highly specialized trading software… But I knew what capabilities that software had. So, I took the essence of it, simplified it and built a stock prediction system. After many attempts, I was able to create a one-screen trading platform… If you'd like to see what Platform X is all about, follow this link here. Analysts' New Coverage Adverum Biotechnologies (NASDAQ:ADVM) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $30.00 price target on the stock. This represents a 195.3% upside from the current price of $10.16. ArriVent BioPharma (NASDAQ:AVBP) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $25.00 price target on the stock. This represents a 52.6% upside from the current price of $16.38. Contineum Therapeutics (NASDAQ:CTNM) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $29.00 price target on the stock. This represents a 86.3% upside from the current price of $15.57. Contineum Therapeutics (NASDAQ:CTNM) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $25.00 price target on the stock. This represents a 60.6% upside from the current price of $15.57. Contineum Therapeutics (NASDAQ:CTNM) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $30.00 price target on the stock. This represents a 92.7% upside from the current price of $15.57. Precision BioSciences (NASDAQ:DTIL) is now covered by analysts at Guggenheim. They set a "buy" rating and a $19.00 price target on the stock. This represents a 92.3% upside from the current price of $9.88. Dyne Therapeutics (NASDAQ:DYN) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $40.00 price target on the stock. This represents a 57.2% upside from the current price of $25.44. Excelerate Energy (NYSE:EE) is now covered by analysts at Stephens. They set an "overweight" rating and a $21.00 price target on the stock. This represents a 22.4% upside from the current price of $17.15. Integral Ad Science (NASDAQ:IAS) is now covered by analysts at Loop Capital. They set a "buy" rating and a $15.00 price target on the stock. This represents a 54.3% upside from the current price of $9.72. Immunome (NASDAQ:IMNM) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $24.00 price target on the stock. This represents a 68.4% upside from the current price of $14.25. Iteris (NASDAQ:ITI) is now covered by analysts at Maxim Group. They set a "buy" rating and a $11.00 price target on the stock. This represents a 145.0% upside from the current price of $4.49. Lexicon Pharmaceuticals (NASDAQ:LXRX) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $5.00 price target on the stock. This represents a 216.5% upside from the current price of $1.58. MINISO Group (NYSE:MNSO) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $30.00 price target on the stock. This represents a 30.5% upside from the current price of $22.98. Ovid Therapeutics (NASDAQ:OVID) is now covered by analysts at B. Riley. They set a "buy" rating and a $9.00 price target on the stock. This represents a 165.5% upside from the current price of $3.39. PVH (NYSE:PVH) is now covered by analysts at Jefferies Financial Group Inc.. They set a "hold" rating and a $115.00 price target on the stock. This represents a 1.9% upside from the current price of $112.90. Ralph Lauren (NYSE:RL) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $195.00 price target on the stock. This represents a 16.7% upside from the current price of $167.03. Red Robin Gourmet Burgers (NASDAQ:RRGB) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $16.00 price target on the stock. This represents a 112.5% upside from the current price of $7.53. Telesat (NASDAQ:TSAT) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "hold" rating and a $9.00 price target on the stock. This represents a 26.1% upside from the current price of $7.14. View today's most recent analysts' new coverage at MarketBeat.com Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. START YOUR 30-DAY FREE TRIAL Calendars from MarketBeat U.S. Analyst Ratings Corporate Buybacks Cryptocurrencies Dividend Declarations Earnings Announcements Economic Reports Gap Up/Down Stocks Insider Trades Initial Public Offerings (IPOs) Most Active Stocks Percentage Gainers/Decliners Sector Performance Short Interest Unusual Options Volume Unusual Trading Volume Upgrade Your Subscription Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. UPGRADE NOW Manage Your Watchlist View and add up to five holdings to your watchlist. VIEW MY PORTFOLIO Join Our Facebook Group Join MarketBeat's free stock discussion and trading idea group on Facebook. JOIN NOW

Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.   If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.   © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.   Today's Bonus Content: Biden to drop out; finish out his term?